SurgePays (SURG) Competitors $2.78 -0.05 (-1.59%) As of 01:58 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipShort InterestTrendsBuy This Stock SURG vs. NYXH, ELMD, PDEX, DRTS, LUNG, INGN, TLSI, LNSR, CVRX, and BWAYShould you be buying SurgePays stock or one of its competitors? The main competitors of SurgePays include Nyxoah (NYXH), Electromed (ELMD), Pro-Dex (PDEX), Alpha Tau Medical (DRTS), Pulmonx (LUNG), Inogen (INGN), TriSalus Life Sciences (TLSI), LENSAR (LNSR), CVRx (CVRX), and BrainsWay (BWAY). These companies are all part of the "medical equipment" industry. SurgePays vs. Nyxoah Electromed Pro-Dex Alpha Tau Medical Pulmonx Inogen TriSalus Life Sciences LENSAR CVRx BrainsWay Nyxoah (NASDAQ:NYXH) and SurgePays (NASDAQ:SURG) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, risk, community ranking, dividends, analyst recommendations, earnings, media sentiment, institutional ownership and profitability. Do analysts prefer NYXH or SURG? Nyxoah currently has a consensus price target of $14.50, indicating a potential upside of 141.26%. SurgePays has a consensus price target of $8.75, indicating a potential upside of 209.19%. Given SurgePays' higher probable upside, analysts clearly believe SurgePays is more favorable than Nyxoah.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nyxoah 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00SurgePays 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is NYXH or SURG more profitable? SurgePays has a net margin of -27.39% compared to Nyxoah's net margin of -1,043.93%. Nyxoah's return on equity of -51.68% beat SurgePays' return on equity.Company Net Margins Return on Equity Return on Assets Nyxoah-1,043.93% -51.68% -40.11% SurgePays -27.39%-55.63%-43.61% Which has more volatility & risk, NYXH or SURG? Nyxoah has a beta of 1.55, indicating that its stock price is 55% more volatile than the S&P 500. Comparatively, SurgePays has a beta of 0.57, indicating that its stock price is 43% less volatile than the S&P 500. Does the MarketBeat Community prefer NYXH or SURG? SurgePays received 129 more outperform votes than Nyxoah when rated by MarketBeat users. However, 73.68% of users gave Nyxoah an outperform vote while only 69.23% of users gave SurgePays an outperform vote. CompanyUnderperformOutperformNyxoahOutperform Votes4273.68% Underperform Votes1526.32% SurgePaysOutperform Votes17169.23% Underperform Votes7630.77% Do insiders and institutionals have more ownership in NYXH or SURG? 6.9% of SurgePays shares are held by institutional investors. 17.1% of Nyxoah shares are held by insiders. Comparatively, 30.5% of SurgePays shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Which has stronger valuation & earnings, NYXH or SURG? SurgePays has higher revenue and earnings than Nyxoah. Nyxoah is trading at a lower price-to-earnings ratio than SurgePays, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNyxoah$4.52M45.28-$46.77M-$1.95-3.08SurgePays$60.88M0.95$20.62M-$2.34-1.21 Does the media refer more to NYXH or SURG? In the previous week, Nyxoah had 2 more articles in the media than SurgePays. MarketBeat recorded 5 mentions for Nyxoah and 3 mentions for SurgePays. SurgePays' average media sentiment score of 0.79 beat Nyxoah's score of 0.39 indicating that SurgePays is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Nyxoah 0 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SurgePays 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummarySurgePays beats Nyxoah on 9 of the 17 factors compared between the two stocks. Get SurgePays News Delivered to You Automatically Sign up to receive the latest news and ratings for SURG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SURG vs. The Competition Export to ExcelMetricSurgePaysTelephone communication, except radio IndustryComputer SectorNASDAQ ExchangeMarket Cap$57.77M$24.21B$23.43B$7.93BDividend YieldN/A13.68%2.96%4.22%P/E Ratio-2.5014.7242.3518.54Price / Sales0.953.532,105.70103.30Price / Cash1.099.0234.7234.62Price / Book1.682.716.184.25Net Income$20.62M$1.01B$737.35M$248.18M7 Day Performance-15.02%0.76%1.23%1.03%1 Month Performance18.91%-0.42%1.65%2.70%1 Year Performance-24.93%9.86%52,704.80%4.05% SurgePays Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SURGSurgePays2.9259 of 5 stars$2.79-1.6%$8.75+214.2%-23.3%$57.17M$60.88M-2.4840NYXHNyxoah2.2914 of 5 stars$5.94-1.5%$14.50+144.1%-36.6%$202.32M$4.52M-3.18110ELMDElectromed1.1015 of 5 stars$22.62-0.7%$38.00+68.0%+30.6%$193.56M$59.63M30.16160Analyst UpgradeNews CoveragePositive NewsPDEXPro-Dex3.038 of 5 stars$58.31-4.1%$52.00-10.8%+261.6%$190.15M$61.00M29.01140Short Interest ↑News CoveragePositive NewsGap DownTrading HaltedDRTSAlpha Tau Medical2.0811 of 5 stars$2.64+2.7%$8.00+203.0%+7.8%$185.81MN/A-6.1480Analyst ForecastAnalyst RevisionNews CoveragePositive NewsLUNGPulmonx3.7103 of 5 stars$4.52flat$12.75+182.1%-51.2%$181.92M$83.79M-3.14250Earnings ReportUpcoming EarningsAnalyst ForecastNews CoverageINGNInogen2.7209 of 5 stars$6.74-1.2%$7.00+3.9%+0.1%$181.22M$335.71M-3.001,030Upcoming EarningsShort Interest ↑TLSITriSalus Life Sciences3.7756 of 5 stars$5.63-1.9%$11.56+105.4%-45.3%$171.68M$29.43M-2.26106Positive NewsGap UpLNSRLENSAR0.8939 of 5 stars$13.79-0.9%$15.00+8.8%+355.7%$162.57M$53.49M-9.45110Upcoming EarningsShort Interest ↑News CoveragePositive NewsCVRXCVRx3.1008 of 5 stars$6.06-3.0%$16.83+177.8%-28.0%$157.78M$51.29M-2.25160Short Interest ↓News CoverageBWAYBrainsWay3.1858 of 5 stars$7.86-4.6%$13.17+67.5%+58.5%$148.31M$41.02M78.61120Upcoming EarningsPositive News Related Companies and Tools Related Companies Nyxoah Competitors Electromed Competitors Pro-Dex Competitors Alpha Tau Medical Competitors Pulmonx Competitors Inogen Competitors TriSalus Life Sciences Competitors LENSAR Competitors CVRx Competitors BrainsWay Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SURG) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTrump Orders 'National Digital Asset Stockpile'Billionaires Rush Into Digital Banking Token Three massive forces are converging right now, creating what c...Crypto 101 Media | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAII predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | SponsoredThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SurgePays, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share SurgePays With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SURG Stock Free SURG Stock Alerts